13.12.2017 • NewsDede WillamsBayerR&D

Bayer Combines Pharma R&D in one Unit

The combined organization will enable us to seamlessly steer all the important...
"The combined organization will enable us to seamlessly steer all the important activities of research and development, with a single objective to further enhance the delivery of much needed new treatment options to patients," said Weinand, president of Bayer's pharmaceuticals division and member of the board of management

From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas cardiology, gynecology, ophthalmology, hematology and oncology.

The new unit will be headed by Joerg Moeller, head of development in the German group’s pharmaceuticals division since Feb. 1, 2014. Moeller will continue to report to Dieter Weinand, president of Bayer's pharmaceuticals division and member of the board of management. He will also be a member of the pharmaceutical executive committee.

Andreas Busch, current head of drug discovery within the pharmaceuticals division, will leave Bayer to join another company.

"The combined organization will enable us to seamlessly steer all the important activities of research and development, with a single objective to further enhance the delivery of much needed new treatment options to patients," said Weinand.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.